| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.25e-12 | 279 | 40 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.02e-09 | 507 | 40 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.02e-09 | 507 | 40 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.30e-08 | 656 | 40 | 11 | GO:0008047 |
| GeneOntologyMolecularFunction | molecular function activator activity | WNT5B TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G INHA TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.47e-07 | 1233 | 40 | 13 | GO:0140677 |
| GeneOntologyMolecularFunction | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity | 5.84e-05 | 6 | 40 | 2 | GO:0017083 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.54e-05 | 1418 | 40 | 11 | GO:0030234 |
| GeneOntologyMolecularFunction | alpha-(1->3)-fucosyltransferase activity | 1.09e-04 | 8 | 40 | 2 | GO:0046920 | |
| GeneOntologyMolecularFunction | fucosyltransferase activity | 3.51e-04 | 14 | 40 | 2 | GO:0008417 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.09e-16 | 109 | 40 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.66e-13 | 244 | 40 | 11 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.68e-11 | 335 | 40 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.83e-09 | 499 | 40 | 11 | GO:0051345 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3E ABL1 TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.37e-07 | 1028 | 40 | 12 | GO:0043085 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.81e-07 | 878 | 40 | 11 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TBC1D3E ABL1 TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.06e-05 | 1430 | 40 | 12 | GO:0044093 |
| GeneOntologyBiologicalProcess | fucose catabolic process | 1.31e-04 | 9 | 40 | 2 | GO:0019317 | |
| GeneOntologyBiologicalProcess | L-fucose catabolic process | 1.31e-04 | 9 | 40 | 2 | GO:0042355 | |
| GeneOntologyBiologicalProcess | L-fucose metabolic process | 1.63e-04 | 10 | 40 | 2 | GO:0042354 | |
| GeneOntologyBiologicalProcess | oligosaccharide metabolic process | 3.38e-04 | 70 | 40 | 3 | GO:0009311 | |
| Domain | TBC | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.48e-18 | 49 | 39 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.22e-18 | 53 | 39 | 10 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.23e-17 | 55 | 39 | 10 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.23e-17 | 55 | 39 | 10 | IPR000195 |
| Domain | Glyco_transf_10 | 1.18e-04 | 8 | 39 | 2 | PF00852 | |
| Domain | Glyco_tran_10_N | 1.18e-04 | 8 | 39 | 2 | PF17039 | |
| Domain | Glyco_trans_10 | 1.18e-04 | 8 | 39 | 2 | IPR001503 | |
| Domain | Glyco_tran_10_N | 1.18e-04 | 8 | 39 | 2 | IPR031481 | |
| Domain | p53-like_TF_DNA-bd | 5.47e-03 | 53 | 39 | 2 | IPR008967 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K | 3.63e-13 | 99 | 30 | 9 | M46448 |
| Pathway | REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS | 1.13e-05 | 21 | 30 | 3 | M27917 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS | 4.36e-05 | 5 | 30 | 2 | M47966 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS | 6.53e-05 | 6 | 30 | 2 | M47967 | |
| Pathway | BIOCARTA_AMAN_PATHWAY | 4.52e-04 | 15 | 30 | 2 | M22009 | |
| Pathway | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | 7.32e-04 | 19 | 30 | 2 | M927 | |
| Pathway | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | 7.32e-04 | 19 | 30 | 2 | MM15523 | |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.03e-33 | 11 | 40 | 11 | 16863688 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 2.60e-12 | 74 | 40 | 7 | 16625196 | |
| Pubmed | 5.63e-09 | 4 | 40 | 3 | 8406013 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 5.63e-09 | 4 | 40 | 3 | 12359748 | |
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 12604796 | ||
| Pubmed | 1.41e-08 | 5 | 40 | 3 | 8471161 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17604274 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 1339443 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 7650030 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 30808544 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 7782074 | ||
| Pubmed | Diversity of human copy number variation and multicopy genes. | 3.87e-06 | 3 | 40 | 2 | 21030649 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 28771224 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 19349624 | ||
| Pubmed | Distinct human α(1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells. | 1.29e-05 | 5 | 40 | 2 | 29593094 | |
| Pubmed | Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism. | 1.34e-04 | 15 | 40 | 2 | 11698403 | |
| Pubmed | 4.45e-04 | 27 | 40 | 2 | 32878924 | ||
| Pubmed | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. | 6.26e-04 | 32 | 40 | 2 | 23535730 | |
| Pubmed | 7.49e-04 | 35 | 40 | 2 | 32281291 | ||
| Pubmed | PHF6 interacts with the nucleosome remodeling and deacetylation (NuRD) complex. | 1.03e-03 | 41 | 40 | 2 | 22720776 | |
| Pubmed | Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. | 1.03e-03 | 41 | 40 | 2 | 23676500 | |
| Pubmed | Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module. | 1.11e-03 | 177 | 40 | 3 | 22560297 | |
| Pubmed | 1.13e-03 | 43 | 40 | 2 | 19077034 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.16e-19 | 149 | 40 | 11 | chr17q12 |
| Cytoband | 17q12 | 2.61e-08 | 99 | 40 | 5 | 17q12 | |
| Cytoband | 12p13.3 | 3.17e-04 | 30 | 40 | 2 | 12p13.3 | |
| Cytoband | 19p13.3 | 1.17e-03 | 237 | 40 | 3 | 19p13.3 | |
| GeneFamily | Fucosyltransferases|Blood group antigens | 8.10e-05 | 13 | 19 | 2 | 434 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.32e-14 | 90 | 38 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.10e-10 | 213 | 38 | 9 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.10e-10 | 213 | 38 | 9 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.42e-10 | 242 | 38 | 9 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.28e-09 | 281 | 38 | 9 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.28e-09 | 281 | 38 | 9 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.98e-09 | 320 | 38 | 9 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | WNT5B SYT1 TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.81e-06 | 1075 | 38 | 11 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | BMPR2 TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.51e-05 | 1153 | 38 | 10 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | WNT5B TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F BIK | 3.46e-05 | 1466 | 38 | 11 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.54e-05 | 1049 | 38 | 9 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.74e-04 | 471 | 38 | 6 | ratio_ECTO_vs_SC_1000_K3 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_1000 | 2.96e-04 | 986 | 38 | 8 | PCBC_ratio_ECTO_vs_SC_1000 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.53e-05 | 172 | 39 | 4 | 1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.95e-05 | 183 | 39 | 4 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.99e-05 | 184 | 39 | 4 | cd2919dc8e90d03f57eb43f59f7da9bcd676496e | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-05 | 198 | 39 | 4 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.65e-05 | 198 | 39 | 4 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| Disease | alpha-(1;3)-fucosyltransferase 5 measurement | 5.99e-06 | 4 | 30 | 2 | EFO_0021979 | |
| Disease | galactoside 3(4)-L-fucosyltransferase measurement | 2.09e-05 | 7 | 30 | 2 | EFO_0021853 | |
| Disease | alpha-(1,3)-fucosyltransferase 5 measurement | 2.09e-05 | 7 | 30 | 2 | EFO_0020136 | |
| Disease | CCL4 measurement | 1.88e-04 | 20 | 30 | 2 | EFO_0004751 | |
| Disease | serum carcinoembryonic antigen measurement | 1.88e-04 | 20 | 30 | 2 | EFO_0005760 | |
| Disease | macrophage inflammatory protein 1b measurement | 3.55e-04 | 136 | 30 | 3 | EFO_0008219 | |
| Disease | candidiasis (implicated_via_orthology) | 9.21e-04 | 44 | 30 | 2 | DOID:1508 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 1.04e-03 | 447 | 30 | 4 | C3714756 | |
| Disease | pyroglutamine measurement | 1.59e-03 | 58 | 30 | 2 | EFO_0005408 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SNDMRLNSWFDPSWR | 516 | Q76B58 | |
| LNSWFDPSWRKRMLL | 521 | Q76B58 | |
| RPNEIPNWTAFSRWK | 2811 | Q68DQ2 | |
| WLPTWRPTSMSQLKN | 16 | Q8TB40 | |
| ENIMRFWRSPNPGSW | 116 | Q13323 | |
| PDMALRQPSRAVWWA | 221 | A6NCF5 | |
| WRLFNCSASLDWPRM | 451 | Q9Y4W2 | |
| MPLDLVRLWQYRPWN | 96 | Q92847 | |
| RWGMPPQDAFTTQWL | 1426 | Q12873 | |
| MTSSLQRPWRVPWLP | 1 | Q13873 | |
| LMRACWQWNPSDRPS | 471 | P00519 | |
| RQGQRWIWFSMESPS | 126 | P51993 | |
| RRSTPLMSWPWSPSA | 231 | P05111 | |
| LMSWPWSPSALRLLQ | 236 | P05111 | |
| LMPQWSRALQPWWSS | 2121 | Q8TDX9 | |
| NFMPIRFQWWLVPLP | 991 | P20648 | |
| PPTRPQGQRWIWFSM | 136 | Q11128 | |
| WSDMLANPRRPIAQW | 391 | P21579 | |
| QPKRRWLFWNSPSSP | 696 | Q9BYZ6 | |
| PFMSQERTVWLPWNS | 986 | Q9NT68 | |
| LNWNTWGMFTRDQPP | 1126 | P14410 | |
| MSLISWLRWNEAPSR | 1 | Q7Z3Z2 | |
| SWRFLQWNSMPRLPT | 446 | B9A6J9 | |
| VNWARRSSLWPMTFG | 71 | O75251 | |
| LNQIPNRRFTLWWSP | 1526 | Q6P2Q9 | |
| SWRFLQWNSMPRLPT | 446 | A6NDS4 | |
| SWRFLQWNSMPRLPT | 446 | P0C7X1 | |
| AMRGIVRTWWSQPPR | 231 | Q8TCY9 | |
| LWMFWPSVNSPLLRS | 216 | P18577 | |
| ALRMNWRVWTPLQFI | 151 | Q9NR77 | |
| SWRFLQWNSMPRLPT | 446 | A6NER0 | |
| LYPNLTRLWDPQVWM | 266 | Q9NSD5 | |
| LWAMLSVPRPSRRFW | 1951 | Q9H5I5 | |
| WWSLALNPVQRPEMF | 26 | Q9H1J7 | |
| SWRFLQWNSMPRLPT | 446 | A0A087X179 | |
| SWRFLQWNSMPRLPT | 446 | A0A087WVF3 | |
| MSLFPNPSWWLLNTS | 256 | Q9BXE9 | |
| SWRFLQWNSMPRLPT | 446 | Q6DHY5 | |
| SWRFLQWNSMPRLPT | 446 | Q8IZP1 | |
| SWRFLQWNSMPRLPT | 446 | A0A087X1G2 | |
| SWRFLQWNSMPRLPT | 446 | A0A087WXS9 | |
| SWRFLQWNSMPRLPT | 446 | Q6IPX1 |